Treatment of obesity: Should we target the individual or society?

Current Pharmaceutical Design

Volumn 9, Issue 15, 2003, Pages 1151-1163

  Antonio Tataranni, P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMFEPRAMONE; AMINOREX; AMPHETAMINE DERIVATIVE; ANTIOBESITY AGENT; BENZPHETAMINE; CANNABINOID RECEPTOR ANTAGONIST; DEXFENFLURAMINE; FENFLURAMINE; FLUOXETINE; GHRELIN; LEPTIN; MAZINDOL; NORADRENALIN UPTAKE INHIBITOR; PEPTIDE YY; PHENDIMETRAZINE; PHENTERMINE; PHENYLPROPANOLAMINE; PLACEBO; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THYROID EXTRACT; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ASTHENIA; BONE DISEASE; CATARACT; CLINICAL TRIAL; CONCENTRATION LOSS; CONSTIPATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TARGETING; ETHNIC GROUP; GASTROINTESTINAL SYMPTOM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HYPERTENSION; INSOMNIA; MEMORY DISORDER; MUSCLE DISEASE; NEUROPATHY; NONHUMAN; OBESITY; PALLIATIVE THERAPY; PARESTHESIA; PATHOGENESIS; PATHOPHYSIOLOGY; POLITICS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; SOMNOLENCE; TACHYCARDIA; VALVULAR HEART DISEASE; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ANIMALS; ANTI-OBESITY AGENTS; ENERGY METABOLISM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; OBESITY; WEIGHT GAIN; WEIGHT LOSS;

EID: 0038324378     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033454946     Document Type: Review

References (109)

1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. JAMA 2003; 289: 76-9.
2. Halsted CH. Am J Clin Nutr 1998; 67: 1-4.
3. NIH-NHLBI Obesity Research 1998; 6: 1-209.
4. Kassirer JP, Angell M. N Engl J Med 1998; 338: 52-4.
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P. et al. N Engl J Med 2001; 344: 1343-50.
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. N Engl J Med 2002; 346: 393-403.
7. Bray GA, Greenway FL. Endocr Rev 1999; 20: 805-75.
8. Neel JV. Am J Hum Genet 1962; 14: 353-62.
9. Ravussin E, Bogardus C. Infusionstherapie. 1990; 17: 108-12.
10. Swinburn B, Egger G, Raza F. Prev Med 1999; 29: 563-70.
11. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Nature 1994; 372: 425-32.
12. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Science 1995; 269: 546-9.
13. Coleman DL. Diabetologia 1973; 9: 294-8.
14. Tartaglia LA. Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Cell 1995; 83: 1263-71.
15. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Nat Med 1995; 1: 1155-61.
16. Cummings DE, Schwartz MW. Annu Rev Med 2003; 54: 453-71.
17. Barsh GS, Schwartz MW. Nat Rev Genet 2002; 3: 589-600.
18. Friedman JM. Nature 2000; 404: 632-4.
19. Saper CB, Chou TC, Elmquist JK. Neuron 2002; 36: 199-211.
20. Tschop M, Heiman ML. Exp Clin Endocrinol Diabetes 2001; 109: 307-19.
21. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott, WG, et al. N Engl J Med 1988; 318: 467-72.
22. Zurlo F, Lillioja S, Esposito-Del PA, Nyomba, BL, Raz I, Saad MF, et al. Am J Physiol 1990; 259: E650-E657.
23. Seidell JC, Muller DC, Sorkin JD, Andres R. Int J Obes Relat Metab Disord 1992; 16: 667-74.
24. Ravussin E, Bogardus C. Br J Nutr 2000; 83 Suppl 1:S17-S20.
25. Schoeller DA, Taylor PB. Hum Nutr Clin Nutr 1987; 41: 215-23.
26. Stunkard AJ, Berkowitz RI, Stallings VA, Schoeller DA. Am J Clin Nutr 1999; 69:524-30.
27. Tataranni PA, Harper IT, Snitker S, Del Parigi A, Vozarova B, Bunt J, et al. Int J Obes Relat Metab Disord 2002; 26: S13.
28. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, et al. Proc Natl Acad Sci USA 1999; 96: 4569-74.
29. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, et al. Diabetes 2000; 49: 838-46.
30. Gautier JF, Del Parigi A, Chen K, Salbe AD, Bandy D, Pratley RE, et al. Obes Res 2001; 9: 676-684.
31. Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, et al. Diabetes 1999; 48: 1801-6.
32. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. Am J Psychiatry 200; 158; 2015-21.
33. Bouchard C, Perusse L. Annu Rev Nutr 1988; 8: 259-77.
34. Allison DB, Kaprio J, Korkeila M, Koskenvuo M, Neale MC, Hayakawa K. Int J Obes Relat Metab Disord 1996; 20: 501-6.
35. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C. Am J Hum Genet 1997; 60: 651-6.
36. Barsh GS, Farooqi IS, O'Rahilly S. Nature 2000; 404: 644-51.
37. Tschop M, Smiley DL, Heiman ML. Nature 2000; 407: 908-13.
38. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. J Clin Endocrinol Metab 2001; 86: 5992.
39. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Nature 2002; 418: 650-4.
40. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, et al. Nat Genet 1997; 15: 273-6.
41. Stone S, Abkevich V, Hunt SC, Gutin A, Russell DL, Neff CD, et al. Am J Hum Genet 2002; 70: 1459-68.
42. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, et al. Am J Hum Genet 1998; 63: 1130-8.
43. Norman RA, Tataranni PA, Pratley R, Thompson DB, Hanson RL, Prochazka M, et al. Am J Hum Genet 1998; 62: 659-68.
44. Lee JH, Reed DR, Li WD, Xu W, Joo EJ, Kilker RL, et al. Am J Hum Genet 1999; 64: 196-209.
45. Chagnon YC, Perusse L, Weisnagel SJ, Rankinen T, Bouchard C. Obes Res 2000; 8: 89-117.
46. Hager J, Dina C, Francke S, Dubois S, Houari M, Vatin V, et al. Nat Genet 1998; 20: 304-8.
47. Hirsch J. Am J Clin Nutr 1998; 67: 2-4.
48. Weyer C, Pratley RE, Salbe AD, Bogardus C, Ravussin E, Tataranni PA. J Clin Endocrinol Metab 2000; 85: 1087-94.
49. Snitker S, Macdonald I, Ravussin E, Astrup A. Obes Rev 2000; 1: 5-15.
50. Black AE, Coward WA, Cole TJ, Prentice AM. Eur J Clin Nutr 1996; 50: 72-92.
51. Ravussin E, Harper IT, Rising R, Bogardus C. Am J Physiol 1991; 261: E402-E409.
52. Prentice AM, Black AE, Coward WA, Cole TJ. Eur J Clin Nutr 1996; 50: 93-7.
53. Grande F, Anderson JT, Keys A. J Appl Physiol 1958; 12: 230-8.
54. Leibel RL, Rosenbaum M, Hirsch J. N Engl J Med 1995; 332: 621-8.
55. Rising R, Harper IT, Fontvielle AM, Ferraro RT, Spraul M, Ravussin E. Am J Clin Nutr 1994; 59: 800-4.
56. O'Rahilly S. Eur J Endocrinol 2002; 147: 435-41.
57. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, et al. Science 2002; 297: 609-11.
58. Ravussin E, Caglayan S, Williamson D, de Jonge L, Thaw JM, Walden H, et al. Int J Obes 2002; 26: S136.
59. Carrel AL, Myers SE, Whitman BY, Allen DB. J Clin Endocrinol Metab 2002; 87: 1581-5.
60. Frayn KN. Clin Dermatol 1989; 7: 48-61.
61. Dixon JL. Curr Opin Lipidol 1994; 5: U143-U150.
62. Frayn KN. Diabetologia 2002; 45: 1201-10.
63. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Science 2000; 289: 950-3.
64. Anand A, Chada K. Nat Genet 2000; 24: 377-80.
65. Tang Q-Q, Otto TC, Lane MD. PNAS 2003; 100: 44-9.
66. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K. Komeda K, et al. J Clin Invest 2001; 108: 1001-13.
67. Picard F, Gehin M, Anniccotte J-S, Rocchi S, Champy M-F, O'Malley BW, et al. Cell 2003; 111: 931-41.
68. Danforth E Jr. Nat Genet 2000; 26: 13.
69. Reitman ML, Arioglu E, Gavrilova O, Taylor SI. Trends Endocrinol Metab 2000; 11: 410-6.
70. Rodrigues B, Cam MC, McNeill JH. Mol Cell Biochem 1998; 180: 53-7.
71. Boden G. Diabetes 1997; 46: 3-10.
72. Rossetti L. Endocrinology 2000; 141:1922.-5.
73. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SI, et al. PNAS 2002; 99: 16309-13.
74. Oral EA, Simha V. Ruiz E, Andewelt A, Premkumar A, Snell P, et al. N Engl J Med 2002; 346: 570-8.
75. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al, N Engl J Med 1999; 341: 879-84.
76. Putnam JJ. Am J Med Sci 1893; 106: 125-48.
77. Masserman JH, Goldsmith H. JAMA 1934; 102: 523-5.
78. Weiss WP. N Engl J Med 2002; 346: 2092-3.
79. Kramer MS, Lane DA. J.Clin.Epidemiol. 1998; 51: 361-4.
80. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al. N Engl J Med 1997; 337: 581-8.
81. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Int J Obes Relat Metab Disord 2002; 26: 262-73.
82. Astrup A, Toubro S. Int J Obes Relat Metab Disord 2001; 25 Suppl 4:S2-S7.
83. Bray GA. J Hum Hypertens. 2002; 16: 1-3.
84. Wooltorton E. CMAJ. 2002; 166: 1307-8.
85. Ravussin E, Tataranni PA. Proc Nutr Soc 1996; 55: 793-802.
86. Vickers SP, Clifton PG, Dourish CT, Tecott LH. Psychopharmacology 1999; 143: 309-14.
87. Smith BK, York DA, Bray GA. Am J Physiol 1999; 277: R802-R811.
88. Guerciolini R. Int J Obes 1997; 21: S12-S23.
89. Brolin RE. JAMA 2002; 288: 2793-6.
90. Sullivan M, Karlsson J, Sjostrom L, Backman L, Bengtsson C, Bouchard C, et al. Int J Obes Relat Metab Disord 1993; 17: 503-12.
91. Sjostrom L. Int J Obes 2002; 26: S3.
92. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, et al. N Engl J Med 1999; 341: 879-84.
93. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, et al. JAMA 1999; 282: 1568-75.
94. Rosenbaum M, Murphy EM, Heymsfield S, Matthews DE, Leibel RL. J Clin Endocrinol Metab 2002; 87: 2391-4.
95. Weinstein S, Vicary C, Ettinger M, Littlejohn T, Schwartz S, Weiss S, et al. Int J Obes 2002; 26: S136.
96. Jain AK, Kaplan RA, Gadde KM, Wadden TA, Allison DB, Brewer ER, et al. Obes Res 2002; 10: 1049-56.
97. Anderson JW, Greenway FL, Fujioka K, Gadde KM, McKenney J, O'Neil PM, et al. Obes Res 2002; 10: 633-41.
98. Bray G, Klein S, Heymsfield S, Fitchet M, Dvorak R, Kumar A. Int J Obes 2002; 26: S82.
99. Brynes AE, Frost GS, Edwards CM, Ghatei MA, Bloom SR. Nutrition 1998; 14: 433-6.
100. Hill JO, Peters JC. Science 1998; 280: 1371-4.
101. Swinburn B, Egger G. In: Bray G, Bouchard C Eds, Influencing obesogenic environments. Handbook of Obesity. 2003.
102. Egan, T. In bid to improve nutrition, schools expel soda and chips. NY Times (A1). 2002; 5-20-2002.
103. Brownell, K. D. and Ludwig, D. S. Fighting obesity and the food lobby. Washington Post (B07). 2002; 6-9-2002.
104. Food=Tobacco? Acord, D. 1. 2003. Washington, CRC Press LLC. Obesity Policy Report.
105. Wang GJ, Volkow ND, Logan. J. Pappas NR, Wong CT, Zhu W, et al. Lancet 2001; 357: 354-7.
106. Del Parigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA. Are we addicted to food. Obes Res 2003 (in press).
107. Banks WA. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 2001; 7(2): 125-33.
108. de Souza CJ, Burkey BF. Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 2001; 7(14): 1433-49.
109. Wagman AS, Nuss JM. Current therapies and emerging targets for the treatment of diabetes. Curr Pharm Des 2001; 7(6): 417-50.